EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus)

O E Latyshev iD, O N Zaykova iD, O V Eliseeva iD, T E Savochkina iD, Y Y Chernoryzh iD, A V Syroeshkin iD, G V Petrov iD, G K Vorkunova iD, V F Larichev iD, I T Fediakina iD, S A Cherepushkin iD, V V Tsibezov iD und 9 weitere

Problems of Virology · 2024

DOI: 10.36233/0507-4088-226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Virology, 2024. Verfasst von O E Latyshev und 20 weiteren Autor:innen. Beteiligte Einrichtung: National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Fe…. Hauptthemen laut MEDLINE: SARS-CoV-2, Vaccines, Virus-Like Particle, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The COVID-19 pandemic caused by SARS-CoV-2 has created serious health problems worldwide. The most effective way to prevent the occurrence of new epidemic outbreaks is vaccination. One of the modern and effective approaches to vaccine development is the use of virus-like particles (VLPs). The aim of the study is to develop a technology for production of VLP based on recombinant SARS-CoV-2 proteins (E, M, N and S) in insect cells. Materials and methods. Synthetic genes encoding coronavirus proteins E, M, N and S were used. VLP with various surface proteins of strains similar to the Wuhan virus, Delta, Alpha and Omicron were developed and cloned into the pFastBac plasmid. The proteins were synthesized in the baculovirus expression system and assembled into VLP in the portable Trichoplusia ni cell. The presence of insertion in the baculovirus genome was determined by PCR. ELISA and immunoblotting were used to study the antigenic activity of VLP. VLP purification was performed by ultracentrifugation using 20% sucrose. Morphology was assessed using electron microscopy and dynamic light scattering.

Results

VLPs consisting of recombinant SARS-CoV-2 proteins (S, M, E and N) were obtained and characterized. The specific binding of antigenic determinants in synthesized VLPs with antibodies to SARS-CoV-2 proteins has been demonstrated. The immunogenic properties of VLPs have been studied.

Conclusion

The production and purification of recombinant VLPs consisting of full-length SARS-CoV-2 proteins with a universal set of surface antigens have been developed and optimized. Self-assembling particles that mimic the coronavirus virion induce a specific immune response against SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Vaccines, Virus-Like ParticleSpike Glycoprotein, CoronavirusCOVID-19BaculoviridaeAnimalsHumansCOVID-19 VaccinesAntibodies, ViralCoronavirus M ProteinsCoronavirus Nucleocapsid ProteinsRecombinant ProteinsViral Matrix ProteinsPhosphoproteins

Stichwörter der Autor:innen

COVID-19SARS-CoV-2Virus-like particlesbaculovirus expression systemrecombinant vaccines

Substanzen

Vaccines, Virus-Like ParticleSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesAntibodies, ViralCoronavirus M ProteinsCoronavirus Nucleocapsid ProteinsRecombinant Proteinsmembrane protein, SARS-CoV-2nucleocapsid phosphoprotein, SARS-CoV-2

Autor:innen und Institutionen

  • National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation.
  • Peoples' Friendship University of Russia.

ORCID-Profile: O E Latyshev, O N Zaykova, O V Eliseeva, T E Savochkina, Y Y Chernoryzh, A V Syroeshkin, G V Petrov, G K Vorkunova, V F Larichev, I T Fediakina, S A Cherepushkin, V V Tsibezov, K A Yuzhakova, N Y Kulikova, V V Lebedeva, D Y Yakunin, A A Kozlova, M S Baranets, K I Yurlov, E I Lesnova, T V Grebennikova

Zitieren

APA

Latyshev, O. E., Zaykova, O. N., Eliseeva, O. V., Savochkina, T. E., Chernoryzh, Y. Y., Syroeshkin, A. V., Petrov, G. V., Vorkunova, G. K., Larichev, V. F., Fediakina, I. T., Cherepushkin, S. A., Tsibezov, V. V., Yuzhakova, K. A., Kulikova, N. Y., Lebedeva, V. V., Yakunin, D. Y., Kozlova, A. A., Baranets, M. S., Yurlov, K. I., …, & Grebennikova, T. V. (2024). Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus). Problems of Virology. https://doi.org/10.36233/0507-4088-226

Vancouver

Latyshev OE, Zaykova ON, Eliseeva OV, Savochkina TE, Chernoryzh YY, Syroeshkin AV, et al. Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus). Problems of Virology. 2024. doi:10.36233/0507-4088-226

BibTeX
@article{Latyshev2024,
  author = {Latyshev, O E and Zaykova, O N and Eliseeva, O V and Savochkina, T E and Chernoryzh, Y Y and Syroeshkin, A V and Petrov, G V and Vorkunova, G K and Larichev, V F and Fediakina, I T and Cherepushkin, S A and Tsibezov, V V and Yuzhakova, K A and Kulikova, N Y and Lebedeva, V V and Yakunin, D Y and Kozlova, A A and Baranets, M S and Yurlov, K I and Lesnova, E I and Grebennikova, T V},
  title = {Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: Orthocoronavirinae: Betacoronavirus: Sarbecovirus)},
  journal = {Problems of Virology},
  year = {2024},
  doi = {10.36233/0507-4088-226}
}
Kostenlos starten →